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Abstract 5 
Low-temperature fermentations produce wines with greater aromatic complexity, but 6 
the success of these fermentations greatly depends on the adaptation of yeast cells to 7 
cold. Tryptophan has been previously reported to be a limiting amino acid during S. 8 
cerevisiae growth at low temperature. The objective of this study was to determine the 9 
influence of the tryptophan metabolism on growth and fermentation performance during 10 
low-temperature wine fermentation. To this end, we constructed the deletion mutants of 11 
the TRP1 and TAT2 genes in a derivative haploid of a commercial wine strain, and the 12 
TAT2 gene was overexpressed in the prototroph and auxotroph (∆trp1) backgrounds. 13 
Then we characterized growth and fermentation activity during wine fermentation at 14 
low and optimum temperatures. Our results partially support the role of this amino acid 15 
in cold yeast growth. Although deletion of TRP1 impaired amino acid uptake and the 16 
growth rate at low temperature in synthetic must, this growth impairment did not affect 17 
the fermentation rate. Deletion of TAT2 endorsed this strain with the highest nitrogen 18 
consumption capacity and the greatest fermentation activity at low temperature. Our 19 
results also evidenced reduced ammonium consumption in all the strains at low 20 
temperature. 21 
 22 
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Introduction 30 
Many winemakers prefer low-temperature fermentation (10-15ºC) for white and “rosé” 31 
wine production because it improves the characteristics of taste and aroma. This 32 
improved aroma profile can be attributed not only to the prevention of volatilization of 33 
primary aromas, but also to the increased synthesis of secondary aromas. Thus the final 34 
wine product has greater terpenes retention, a reduction in higher alcohols, and an 35 
increased proportion of ethyl and acetate esters in the total volatile compounds.
 1-3
 36 
Another positive aspect is that low temperatures diminish the growth of acetic and lactic 37 
bacteria, which makes alcoholic fermentation control easier. 
4
 However, low 38 
temperatures lower the growth rate and prolong the lag phase, which lead to longer 39 
fermentations and increase the risk of producing sluggish, stuck fermentations.
5 
40 
Therefore, the quality of wines produced at low temperature depends on the yeast’s 41 
ability to adapt to cold. 42 
The nitrogen fraction in grape must consists of organic (amino acids) and inorganic 43 
(ammonium) nitrogen. Saccharomyces cerevisiae is able to regulate nitrogen uptake by 44 
the so-called nitrogen catabolite repression (NCR) mechanism.
6
 Recently, Crepin et al.
7
 45 
determined the consumption kinetics of the amino acids and ammonium present in a 46 
synthetic grape must. These authors found that the assimilation sequence of the nitrogen 47 
compounds during fermentation is largely determined by the kinetic characteristics and 48 
regulation of the transporters of amino acids and ammonium. Most late consumed 49 
amino acids (i.e., arginine and alanine) are transported by permeases under NCR, except 50 
valine, tryptophan and tyrosine, which are transported by SPS-regulated permeases.
7
 51 
Quiros et al.
8
 mostly confirmed the order of consumption of the different nitrogen 52 
sources reported previously by Crepin et al.
7
 These authors also observed that the 53 
consumption of amino acids is also affected by both sugar concentration and 54 
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temperature. Beltran et al.
9 
showed that cells growing at low temperature had a less 55 
effective NCR, which resulted in a higher uptake of two of these late consumed amino 56 
acids, arginine and tryptophan, and that the consumption of glutamine, one of the earlier 57 
consumed and more preferred amino acids, was lower. These authors
9
 also reported that 58 
the consumption of ammonium in cells growing at low temperature significantly 59 
diminished. 60 
It has been reported that tryptophan uptake at low temperature is a rate-limiting step for 61 
S. cerevisiae growth.
10
 Broad-range permease (Gap1p), or specific amino acid 62 
permeases Tat1p and Tat2p, are able to transport tryptophan into the cell. Tat2p 63 
mediates the high-affinity uptake of tryptophan, and Tat1p mediates the low-affinity 64 
uptake of this amino acid.
11
 Low temperature increases the rigidity of the plasma 65 
membrane
12
, which results in the slower lateral diffusion of membrane proteins, less 66 
active membrane-associated enzymes, and a major reduction in membrane transport.
13
 67 
Membrane permeases are highly temperature-dependent because changes in temperature 68 
can cause conformational changes in their structure
14
. Sensitivity of tryptophan uptake 69 
at low temperature has been related to a dramatic conformational change in Tat2p. Abe 70 
and Horikoshi
15
 demonstrated that the overexpression of TAT2 in a laboratory S. 71 
cerevisiae strain confers yeast cells good capacity to grow at low temperature. 72 
Moreover, enhancement of the gene expression for tryptophan biosynthesis or uptake 73 
has also been related to ethanol stress tolerance.
16
 Recently in a metabolic comparison 74 
between a wine strain of S. cerevisiae and a cryotolerant strain of S. bayanus,
17
 we 75 
detected more active tryptophan biosynthesis in the cryotolerant strain via the shikimate 76 
pathway, which partially explains its improved growth at low temperature. 77 
The aim of this study was to analyze the importance of tryptophan biosynthesis and 78 
uptake in a context which mimics wine fermentation conditions. First we deleted the 79 
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TRP1 gene, which is involved in tryptophan biosynthesis, and the TAT2 gene, which is 80 
related to tryptophan uptake, in the genetic background of a derivative haploid of the 81 
commercial wine strain QA23. We also constructed strains which overexpressed the 82 
TAT2 gene in the background of the wine strain and in its auxotroph for tryptophan 83 
(∆trp1). Then we analyzed the effect of deletions and overexpression on growth and 84 
fermentation activity during wine fermentations at low and optimum temperatures.  85 
  86 
Materials and Methods 87 
Construction of the mutant and overexpressing strains 88 
The TAT2 and TRP1 genes were deleted on the derivative haploid of the commercial 89 
wine strain QA23 (Lallemand S.A., Canada) hoQA23.
18
 The primers used to construct 90 
the mutant and overexpressing strains are listed in Table 1. The TAT2 and TRP1 genes 91 
were deleted using the short flanking homology (SFH) method
19
 based on the KanMX4 92 
and the NatMX4 deletion cassette, respectively, which provided geneticin (G418) and 93 
nourseothricin resistance. Given the high GC content of the NAT1 gene encoding 94 
nourseothricin-resistance, the PCR reaction mixture contained 5% of DMSO, as 95 
previously described.
20 
The deletion cassettes were used to transform the haploid 96 
hoQA23 strain by the lithium acetate procedure.
21
 After selecting the transformants in 97 
YPD with geneticin (G418) or noursethricin (clonNAT), the correct insertion of the 98 
deletion cassettes was also verified by PCR using the primers upstream and downstream 99 
of the deleted region, combined with the primers of the KanMX4 or NatMX4 genes 100 
(Table 1). 101 
The TAT2 gene was overexpressed by cloning it into the centromeric plasmid 102 
pGREG505 in strains hoQA23 and hoQA23 (∆trp1), as described in Jansen et al.
22
 103 
TAT2 was amplified from approximately 600 nucleotides upstream of the start codon to 104 
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400 nucleotides downstream of the stop codon in order to ensure that the promoter and 105 
terminator regions were included. The PCR protocol involved an initial denaturation at 106 
94ºC (2 min), followed by 30 cycles of 10 s at 94ºC, 30 s at 52ºC and 3 min at 72ºC. 107 
The last cycle was followed by a final extension step of 10 min at 72ºC. PCR fragments 108 
were generated with oligonucleotides containing short sequences rec5 (forward) and 109 
rec2 (reverse), which are homologous to the sequences in the plasmid (about 35 bp). 110 
The plasmid was linearized by SalI digestion and digested with AscI to avoid sticky 111 
ends and to make the recombination process easier.
22
 Derivative wine yeasts hoQA23 112 
and hoQA23 (∆trp1) were co-transformed with the digested pGREG505 plasmid, 113 
together with the PCR-amplified target gene that was flanked by recombination 114 
sequences homologous to the plasmid ends. This co-transformation promotes an in vivo 115 
homologous recombination between both fragments. This recombination process also 116 
deleted the GAL1 promoter of the plasmid (genes were cloned with their own 117 
promoters). Transformants were selected by geneticin resistance, which is encoded by 118 
the KanMX4 gene in the plasmid. Correct integration of the gene into the vector was 119 
verified by plasmid DNA isolation using a modified version of the protocol described 120 
by Robzyk and Kassir
23
, and further PCR amplification was performed with the primers 121 
specified for sequences rec5 and rec2 (Table 1). 122 
 123 
Growth media 124 
Strains were cultured in the synthetic grape must (SM) (pH 3.3) described by Riou et 125 
al.
24
, but with 200 g/L of reducing sugars (100 g/L glucose + 100 g/L fructose) and 126 
without anaerobic factors.
25
 The following were utilized: organic acids, malic acid 5 127 
g/L, citric acid 0.5 g/L and tartaric acid 3 g/L; mineral salts KH2PO4 750 mg/L, K2SO4 128 
500 mg/L, MgSO4 250 mg/L, CaCl2 155 mg/L, NaCl 200 mg/L, MnSO4 4 mg/L, ZnSO4 129 
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4 mg/L, CuSO4 1 mg/L, KI 1 mg/L, CoCl2 0.4 mg/L, H3BO3 1 mg/L and (NH4)6Mo7O24 130 
1 mg/L; vitamins myo-inositol 20 mg/L, calcium pantothenate 1.5 mg/L, nicotinic acid 131 
2 mg/L, chlorohydrate thiamine 0.25 mg/L, chlorohydrate pyridoxine 0.25 mg/L and 132 
biotin 0.003 mg/L. The assimilable nitrogen source used was 300 mg N/L (120 mg N/L 133 
as ammonium and 180 mg N/L in the amino acid form). Tryptophan represented 134 
approximately 6.5% of the total assimilable organic nitrogen (12 mg N/L). 135 
The population inoculated in the synthetic grape must came from an overnight culture in 136 
YPD (1% yeast extract, 2% peptone, 2% glucose) at 30ºC. After counting 137 
microscopically, the appropriate dilution of the overnight culture was transferred to SM 138 
to achieve an initial cell concentration of 2 x 10
6 
cells/mL. 139 
 140 
Gene expression analysis by real-time quantitative PCR 141 
The total RNA of 10
8 
cell/mL was isolated from the different samples, as described by 142 
Sierkstra et al.
26
, and was resuspended in 50 µL of DEPC-treated water. Total RNA 143 
suspensions were purified using the High Pure Isolation kit (Roche Applied Science, 144 
Germany), following the manufacturer’s instructions. RNA concentrations were 145 
determined in a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, 146 
USA), and RNA quality was verified electrophoretically in 0.8% agarose gel. Solutions 147 
and equipment were treated to leave them RNase-free, as outlined in Sambrook et al.
27
 148 
Total RNA was reverse-transcribed with Superscript
TM
 II RNase H
-
 Reverse 149 
Transcriptase (Invitrogen, USA) in a GenAmp PCR System 2700 (Applied Biosystems, 150 
USA). The reaction contained 0.5 µg of Oligo (dT)12-18 primer (Invitrogen, USA) and 151 
0.8 µg of total RNA as a template in a total reaction volume of 20 µL. Following the 152 
manufacturer’s guidelines, cDNA was synthesized at 42ºC for 50 min after denaturation 153 
at 70ºC for 10 min. Then the reaction was inactivated at 70ºC for 15 min. 154 
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The primers of the TAT2 gene were designed according to the Saccharomyces Genome 155 
Database. The primers of housekeeping gene ACT1 have been previously described by 156 
Beltran et al.
25
 (Table 1). Amplicons were shorter than 100 bp, which ensured maximal 157 
PCR efficiency and the most precise quantification. Real-time quantitative PCR was 158 
performed using the LightCycler

 480 SYBR Green I Master (Roche, Germany). The 159 
SYBR PCR reactions contained 2.5µM of each PCR primer, 5 µL of cDNA and 10 µL 160 
of SYBR Green I Master (Roche, Germany) in a 20-µL reaction.  161 
All the PCR reactions were mixed in a LightCycler

 480 Multiwell Plate 96 (Roche, 162 
Germany) and cycled in a LightCycler

 480 Instrument II, 96-well thermal cycler 163 
(Roche, Germany) under the following conditions: 95ºC for 5 min, and 45 cycles at 164 
95ºC for 10 sec, at 60ºC for 10 sec and 72ºC 10 sec. Each sample had two controls that 165 
were run in the same PCR: no amplification control (sample without reverse 166 
transcriptase reaction) to avoid interference by contaminant genomic DNA, and no 167 
template control (sample without RNA template) to avoid interference by primer-dimer 168 
formation. All the samples were analyzed in triplicate with the LightCycler

 480 169 
Software, version 1.5 (Roche, Germany), and the expression values were averaged. The 170 
gene expression levels of TAT2 in the overexpressing strains are shown as a relative 171 
value in comparison to their control strains, hoQA23-pGREG and pGREG (∆trp1). 172 
Housekeeping gene ACT1 was used as an endogenous reference gene to normalize input 173 
amounts. This endogenous ACT1 gene showed excellent uniformity in the expression 174 
levels of all the study samples.  175 
 176 
Generation time (GT) 177 
Growth was monitored at 600 nm in a SPECTROstar Omega instrument (BMG 178 
Labtech, Germany) at 12ºC and 28ºC. Measurements were taken after pre-shaking the 179 
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microplate for 20 sec every 30 min for 3 days. At 12ºC, the microplate had to be 180 
incubated outside the SPECTROstar spectrophotometer and was then moved inside to 181 
take measurements every 8 hours in the lag phase and every 3 hours in the exponential 182 
phase. Microplate wells were filled with 0.25 mL of SM medium to reach an initial OD 183 
of approximately 0.2 (inoculum level of 2 x 10
6
 CFU/mL). Uninoculated wells for each 184 
experimental series were also included in the microplate to determine, and to 185 
consequently subtract, the noise signal. All the experiments were carried out in 186 
triplicate. 187 
Growth parameters were calculated from each treatment by directly fitting OD 188 
measurements versus time to the reparameterized Gompertz equation proposed by 189 
Zwietering et al.
28
: 190 
 y=D*exp{-exp[((µmax*e)/D)*(λ-t))+1]}   191 
where y=ln(ODt/OD0), OD0 is the initial OD, ODt is the OD at time t, D=ln(ODt/OD0) is 192 
the asymptotic maximum, µmax is the maximum specific growth rate (h
-1
), and λ is the 193 
lag phase period (h).
29
 Generation time (GT) was calculated using the GT=ln2/µmax 194 
equation.  195 
Fermentations 196 
Fermentations were performed at 28ºC and 12ºC with continuous orbital shaking at 100 197 
rpm, using 100-mL bottles filled with 60 mL of SM fitted with caps that enabled carbon 198 
dioxide to escape and samples to be removed. The population inoculated in each flask 199 
was 2 x 10
6
 cells/mL from an overnight culture in YPD. Fermentation was monitored by 200 
measuring media specific density with a Densito 30 PX densitometer (Mettler Toledo, 201 
Switzerland). Fermentation was considered complete when density was below 0.998. 202 
Yeast cell growth was also determined by absorbance at 600 nm and by plating samples 203 
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at the end of fermentation on YPD medium in serial decimal dilutions, and they were 204 
incubated at 28ºC for 2 days. 205 
 206 
Nitrogen content analysis 207 
Samples were taken at 74 h and 240 h at 28ºC and 12ºC, respectively (around 1.020 of 208 
specific density), during fermentation. The individual amino acids present in the media 209 
were analyzed by OPA and FMOC derivatizations with the Agilent 1100 Series HPLC, 210 
as described in Beltran et al.
25
 Each amino acid concentration was calculated using 211 
external and internal standards, and was expressed as mg N/L. The Agilent ChemSation 212 
Plus software was used (Agilent Technologies, Germany). 213 
 214 
Statistical data processing 215 
All the experiments were repeated at least 3 times and data were reported as the mean 216 
value ± SD. Significant differences among the control strain, the mutant and the 217 
overexpressing strains were determined by t-tests (the SPSS 13 software package). The 218 
statistical level of significance was set at P ≤ 0.05. 219 
A principal component analysis (PCA) was done using the vegan package (the rda 220 
function) of the R v.2.15 statistical software (R Development Core Team, 2010).
30
 221 
 222 
Results 223 
Gene expression analysis of overexpressing strains by real-time quantitative 224 
PCR 225 
After constructing the overexpressing strains, we aimed to validate and quantify the 226 
gene expression in these strains. Samples were taken at time 0 h (before inoculation), 6 227 
and 18 h after inoculation in the synthetic grape must (SM) at low temperature (12ºC). 228 
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The relative expression values of TAT2 are shown in Figure 1. The two overexpressing 229 
strains showed a significant overexpression of TAT2 at time 0 h, which was 4-fold 230 
greater than the control for the pGREG TAT2 strain and 27-fold greater than the control 231 
for the pGREG TAT2 (∆trp1) strain. Moreover, the pGREG TAT2 (∆trp1) strain also 232 
showed overexpression at 6 h and 18 h after inoculation (20- and 5.5-fold more than the 233 
control, respectively). 234 
 235 
Phenotype effect of the mutant and overexpressing strains 236 
Determination of generation time (GT) 237 
In order to determine the effect of the TRP1 and TAT2 deletions on growth, and the 238 
overexpression of TAT2, in two different genetic backgrounds (tryptophan prototroph 239 
and auxotroph), the GT of the mutant and overexpressing strains at 12ºC and 28ºC in 240 
the SM were calculated (Table 2). No significant differences in the growth rate of the 241 
TAT2 mutant and the overexpressing strains were found, and only the ∆trp1 strain 242 
showed lower growth rate than its control strain, hoQA23, at both temperatures. 243 
Fermentation activity 244 
The fermentation activity of the mutant and overexpressing strains was estimated by 245 
calculating the time required to ferment 5% (T5), 50% (T50) and 100% (T100) of the 246 
sugars in the SM (Fig. 2). T5, T50 and T100 approximately matched the beginning (lag 247 
phase), middle (end of exponential phase) and end of fermentation, respectively. At the 248 
beginning of fermentation (T5), no differences were observed at low temperature. The 249 
∆tat2 strain displayed greater fermentation activity at low temperature, and required a 250 
considerably shorter time to consume 50% and 100% of the sugars (17 h and 60 h less, 251 
respectively) if compared to the fermentation of the control hoQA23 strain at 12ºC. 252 
Conversely this strain finished later than the control for the fermentation at 28ºC. 253 
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pGREG TAT2 also finished earlier at 12ºC if compared to its control (hoQA23-254 
pGREG), but took longer to finish the fermentation at 28ºC. pGREG TAT2 (∆trp1) was 255 
able to finish fermentation at 28ºC before its control pGREG (∆trp1), but no differences 256 
were found at 12ºC. These differences in fermentation activity cannot be ascribed to 257 
biomass production because non significant differences were observed in the viable 258 
population at the end of the fermentations among the different strains and temperatures, 259 
except for the ∆trp1 strain, which showed a larger population size at 28ºC (Table 3). 260 
 261 
Nitrogen consumption of mutant and overexpressing strains 262 
Different nitrogen requirements in yeast fermenting were observed at both temperatures.  263 
At the same fermentation point (around 1.020 of specific density, which matches the 264 
end of the exponential phase), nitrogen consumption by yeast was generally lower at 265 
12ºC than at 28ºC (Table 4). These differences between both temperatures were greater 266 
for ammonium consumption. Major differences in the amino acids present in the SM 267 
between the temperatures were observed in the tryptophan auxotroph strains (∆trp1 and 268 
pGREG (∆trp1)). Conversely mutations and overexpressions did not significantly 269 
modify the uptake of ammonium and amino acids at the same temperature. Only 270 
pGREG TAT2 (∆trp1) at 28ºC consumed more amino acids and ammonium than its 271 
control pGREG (∆trp1). 272 
In order to explore the effect of deletion/overexpression and temperature fermentation 273 
on ammonium and amino acid preferences, a PCA was carried out (Fig. 3). This PCA 274 
was performed on the seven strains using the residual concentration (mg N/L) of 20 275 
amino acids and ammonium measured in the SM at the analyzed fermentation time 276 
point (1.020 of specific density) (Table S1). The first two components were retained and 277 
explained 86.7% of total variance. The first component (PC1) explained 68.8% of 278 
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variation, and was marked by a high positive component loading for histidine (+0.366) 279 
and high negative loadings for glutamine (-0.755) and ammonium (-0.509). The second 280 
component explained 17.9% of variation, and was marked by a high positive component 281 
loading for glutamine (+0.495) and a high negative loading for ammonium (-0.841). 282 
This result revealed the different nitrogen preferences at both temperatures. The most 283 
evident result was that control strain hoQA23 and its mutants consumed more histidine 284 
at the low temperature, and more glutamine and ammonium at the optimum 285 
temperature.  286 
 287 
Discussion 288 
Low temperature produces several effects on biochemical and physiological properties 289 
in yeast cells. Recently in their metabolomic study on wine fermentations at low 290 
temperature, López-Malo et al.
17
 reported that the main differences in the metabolic 291 
profiling of the S. cerevisiae industrial strain QA23 growing at 12ºC and 28ºC were 292 
observed in the lipid and amino acid metabolisms. These differences in metabolites 293 
might be related to the previously reported different nitrogen consumption pattern at 294 
low temperature,
8,9
 or with the greater demand of some specific amino acids at low 295 
temperature, such as tryptophan.
8,10
 In this study, most strains also showed higher 296 
nitrogen consumption at the optimum temperature than at 12ºC. As already reported by 297 
Beltran et al.
9
, the main differences in nitrogen use at both temperatures are accounted 298 
for by ammonium consumption. This result supports the idea that there is a problem 299 
with the uptake or metabolization of one of the main nitrogen sources at low 300 
temperature.
9
 As previously reported
31
, low temperature exerts strong nutritional stress, 301 
similarly to growth under nitrogen-limiting conditions. Regarding amino acid 302 
consumption, only the tryptophan auxotroph strains (∆trp1 and pGREG (∆trp1)) 303 
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exhibited impaired amino acids uptake at low temperature, which was not affected at the 304 
optimum temperature. This lower amino acid consumption resulted in a growth defect 305 
in the ∆trp1 strain, which showed a longer GT at 12ºC in comparison with the wild 306 
type, as previously reported.
32
 Nevertheless, we also observed impaired growth at the 307 
optimal temperature. It is important to consider that our experimental approach differs 308 
substantially from those previously reported using laboratory strains and growth 309 
conditions in standard laboratory media. We used an industrial wine strain to mimic 310 
wine fermentation conditions. Similar non fitting results were also obtained from the 311 
fermentation activity of this ∆trp1 strain. Some authors have revealed that the deletion 312 
mutants of tryptophan biosynthesis show ethanol-sensitive growth at the optimal 313 
temperature.
16
 In comparison with the control strain however, no significant differences 314 
were found with the ∆trp1 strain during the time required to complete fermentation. 315 
The cold-sensitive phenotype of the ∆trp1 strain has been related with impaired 316 
tryptophan uptake. Abe and Horikoshi
15
 postulated that the increased rigidity of the 317 
plasma membrane at low temperature induces conformational changes in permease 318 
Tat2p and impairs tryptophan transport. In the present study, no differences were found 319 
in the growth rate of ∆tat2 at both temperatures if compared to hoQA23. Thus in this 320 
industrial strain, tryptophan uptake must be compensated by the action of other 321 
permeases, such as low-affinity tryptophan permease, Tat1p or the general amino acid 322 
permease Gap1p. Although it was not statistically significant, this strain consumed more 323 
amino acids and ammonium than its control strain hoQA23 at low temperature. 324 
However one unexpected result revealed that this strain also displayed better 325 
fermentation performance at low temperature. Although this direct correlation between 326 
TAT2 deletion and fermentation improvement at low temperature should be confirmed 327 
with other industrial strains, our working hypothesis is that the greater nitrogen uptake 328 
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of this strain produces a fermentation activity stimulus. Regulation of glycolytic 329 
enzymes by ammonium and amino acids uptake has been widely reported.
33,34
  330 
Abe and Horikoshi
15
 demonstrated that the cells expressing Tat2p at high levels are 331 
endowed with the ability to grow under low-temperature conditions in a tryptophan 332 
auxotroph laboratory strain. However, the present study evidences no growth 333 
improvement with the overexpression of TAT2 in either the prototroph or the auxotroph 334 
background, and this result highlights the importance of the genetic background. As 335 
with the mutant strain, the overexpression of TAT2 also significantly reduced 336 
fermentation time.  337 
Unexpectedly tryptophan uptake showed few differences between the different strains 338 
and temperature. This amino acid was practically consumed completely under all the 339 
fermentation conditions (Table S1). The PCA only revealed lower ammonium and 340 
glutamine consumption, as previously reported,
9
 and higher histidine consumption at 341 
low temperature, which has not been reported to date. 342 
 343 
Conclusions 344 
One conclusion drawn from this study is the need to test the phenotypes observed in the 345 
mutant laboratory strain in the genetic background of industrial strains under conditions 346 
that mimic the industrial process. Our experience has revealed that many of these 347 
phenotypes are not reproduced when transferred to more complex, robust and polyploid 348 
industrial strains.
35,36 
Tryptophan has been previously reported to be a limiting amino 349 
acid during S. cerevisiae growth at low temperature, and the results of the present study 350 
partially support this assessment. Deletion of TRP1, a key gene of tryptophan 351 
biosynthesis, impaired the growth rate at low temperature in synthetic must. However, it 352 
was also affected at 28ºC. Thus the cold sensitivity of this strain in this genetic 353 
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background was not absolutely conclusive. Moreover this growth impairment did not 354 
affect the fermentation rate. A more evident phenotype in ∆trp1 was the lowest amino 355 
acid consumption noted at low temperature, which might explain its lower growth rate. 356 
Strangely enough, the overexpression of TAT2 in the ∆trp1 strain did not reveal that 357 
nitrogen consumption recovered sufficiently, whereas deletion of TAT2 (∆tat2) 358 
endorsed this strain with the highest nitrogen consumption capacity at low temperature. 359 
This strain underwent significant reduction during the time required to complete 360 
fermentation at low temperature. Although this result was unexpected, it may prove 361 
promising to meet the objective of obtaining industrial strains with improved 362 
fermentation capacity at low temperature through the selection of proper strains or the 363 
genetic modification of current industrial yeast. 364 
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Figure legends 471 
Figure 1. Relative expression of TAT2 during SM fermentation at 12ºC. Changes in 472 
gene expression in the overexpressing strains are shown as compared to their controls, 473 
hoQA23-pGREG and pGREG (∆trp1), at the same fermentation point (0 h, 6 h and 18 474 
h), set as value 1. Values higher than 1 indicate a higher gene expression than the 475 
control, whereas those lower than 1 denote a lower gene expression than the control. 476 
*Statistically significant differences (P-value ≤ 0.05) versus their control strains. 477 
Figure 2. Determination of the time required by the mutant and overexpressing strains 478 
to ferment 5% (T5), 50% (T50) and 100% (T100) of the initial sugar content in a 479 
synthetic must at 12ºC (gray bars) and 28ºC (black bars). Positive and negative values 480 
represent the increases and decreases in time (h) of the mutant and overexpressing 481 
strains if compared to the control strains (normalized as value 0). The fermentation 482 
times of the control strains were: hoQA23 at 12ºC T5 = 62.75 h ± 2.29 h, T50 = 176.75 483 
h ± 3.77 h T100 = 371.75 h ± 8.66 h; at 28ºC T5 = 17.94 h ± 2.26 h, T50 = 50.12 h ± 484 
3.99 h, T100 = 133.84 h ± 8.66 h and hoQA23-pGREG at 12ºC T5 = 81.75 h ± 5.20 h, 485 
T50 = 176.75 h ± 16.75 h, T100 = 361.75 h ± 1.73 h; at 28ºC T5 = 21.85 h ± 1.13 h, 486 
T50 = 53.82 h ± 2.10 h, T100 = 136.34 h ± 13.56 h. pGREG (∆trp1) at 12ºC T5 = 487 
47.75 h ± 1.73 h, T50 = 151.75 h ± 7.40 h, T100 = 341.75 h ± 4.82 h; at 28ºC T5 = 488 
20.12 h ± 1.36 h, T50 = 53.38 h ± 1.36 h, T100 = 148.41 h ± 1.85 h. *Statistically 489 
significant differences (P-value ≤ 0.05) as compared with their control strains. 490 
Figure 3. Biplot of the first two PCA components according to the residual amino acids 491 
present in synthetic must at a specific density of 1.020 in the 28ºC and 12ºC 492 
fermentations. Variables are represented in gray and samples are denoted in black. 493 
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Table 1. List of the DNA sequences of the oligonucleotides used in this study. 
Primer SEQUENCE (5´→ 3´) Use  
TRP1-K1
a 
ATGTCTGTTATTAATTTCACAGGTAGTTCTGGTCCATTGGCGTACGCTGCAGGTCGAC Deletion TRP1  
TRP1-K2
a 
ATTGTTTTATCGTTTAAAGCAGTTTTTACGATTCTTTATCATCGATGAATTCGAGCTCG Deletion TRP1  
cmTRP1F AAAGACATGGAGGGCGTTAT Verification deletion TRP1  
cmTRP1R GCACTCCTGATTCCGCTAATA Verification deletion TRP1  
TAT2- S1
b
 GCAAACAATTACCCGGAAATAGGGCTTAAATCAAGAATAAACCCCTAATTCGTACGCTGC
 
Deletion TAT2  
TAT2-C2b GAAGTCCTCATCCACGTATTCAAATGATAATTTTTCAAAATGTCAGGTTTACTAGTGGAT Deletion TAT2  
TAT2-ovF CATGTCCGATAGCGGGAACTGA Verification deletion TAT2  
TAT2-ovR ATTATCGCATGCAAACCAACTTGGCTACCG Verification deletion TAT2  
TAT2rec5F
c 
AACAAAAGCTGGAGCTCGTTTAAACGGCGCGCCCATGTCCGATAGCGGGAACTGA  Overexpression TAT2  
TAT2rec2R
c
 GCGTGACATAACTAATTACATGACTCGAGGTCGACATTATCGCATGCAAACCAACTTGGCTACCG   Overexpression TAT2  
rec5Fc AACAAAAGCTGGAGCTCGTTTAAACGGCGCGCC Verification overexpression TAT2  
rec2R
c 
GCGTGACATAACTAATTACATGACTCGAGGTCGAC Verification overexpression TAT2  
TAT2F CTGGCCACGTGCATTGTCT Real-time quantitative PCR TAT2  
TAT2R GCCTTCATCGCCAGTCTAAATC Real-time quantitative PCR TAT2  
ACT1F TGGATTCCGGTGATGGTGTT Real-time quantitative PCR ACT1  
ACT1R CGGCCAAATCGATTCTCAA Real-time quantitative PCR ACT1  
a 
The sequence with homology to the plasmid pAG25 is underlined. The remainder of the primer sequences is homologous to the flanking region 
of the deleted ORF. 
b 
The sequence with homology to the plasmid pUG6 is underlined. The remainder of the primer sequences is homologous to the flanking region 
of the deleted ORF. 
c 
The recombination sequences homologous to the plasmid pGREG 505 ends are underlined. 
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Table 2. Generation time (GT) of the strains.   
 
Strain 12ºC 28ºC 
hoQA23 22.73 ± 0.48 4.82 ± 0.15 
∆tat2 24.20 ± 1.35 4.76 ± 0.10 
∆trp1   25.56± 1.26 *    6.00 ± 0.12 * 
hoQA23 pGREG 25.55 ± 1.16 4.78 ± 0.14 
pGREG TAT2 24.47 ± 0.72 4.99 ± 0.11 
pGREG (∆trp1) 26.00 ± 2.62 4.71 ± 0.13 
pGREG TAT2 (∆trp1) 24.11 ± 0.18 4.81 ± 0.09 
 
* Statistically significant differences (P-value ≤ 0.05) as compared with their control 
strain at the same temperature. 
 
 
 
 
Table 3.   Viable cells (CFU/mL (10
7
) at the end of fermentation at 12ºC and 28ºC. 
 
 
Viable cells (CFU/mL (10
7
)) 
Strain 12ºC 28ºC 
hoQA23 4.40 ± 1.04 7.53 ± 1.72 
∆tat2 5.20 ± 1.76  5.37 ± 0.42 
∆trp1 2.80 ± 0.14   13.83 ± 1.20* 
hoQA23 pGREG 7.97 ± 2.76 5.20 ± 2.43  
pGREG TAT2 5.70 ± 2.91 6.57 ± 2.37  
pGREG (∆trp1) 4.60 ± 2.34 4.43 ± 1.82  
pGREG TAT2 (∆trp1) 4.37 ± 1.80  4.50 ± 0.44 
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Table 4. Residual Yeast Assimilable Nitrogen (YAN) in the synthetic must (SM) at 1.020 density of fermentation at 28ºC and 12ºC, expressed as 
amino acid (YANaa) and ammonia (YAN NH4)  (mg N /L) 
 
 
Strain hoQA23 ∆tat2 ∆trp1 hoQA23 pGREG pGREG TAT2 pGREG (∆trp1) pGREG TAT2 (∆trp1) 
28ºC        
YANaa 85.67 ± 11.34 90.12 ± 2.16 68.18 ± 9.67 102.32 ± 4.50 102.85 ± 13.20 87.57 ± 0.73 78.75 ± 3.90a 
YAN NH4 2.01 ± 0.43 3.58 ± 2.72 1.56 ± 0.18 1.73 ± 0.07 10.03 ± 7.61 1.62 ± 0.01 1.52 ± 0.03a  
Total YAN 90.80 ± 16.77 93.71 ± 4.88 69.73 ± 9.80 104.11± 3.94 112.87 ± 19.43 89.20 ± 0.50 80.27 ± 3.93  
12ºC        
YANaa 102.24 ± 7.92 76.27 ± 15.84 114.33± 8.19b 109.64 ± 0.88 118.96 ± 6.90 120.47 ± 11.10 b 105.62 ± 18.93 
YAN NH4 38.24 ± 5.73 b 11.29 ± 9.83 20.62 ± 3.05b 22.88 ± 2.98b 17.72 ± 4.77 14.28 ± 10.19 b 14.41± 13.79 
Total YAN 140.48 ± 13.65b 87.55 ± 25.67 134.96 ± 11.25b 132.52 ± 2.09b 136.68 ± 5.33 134.75 ± 21.28 120.04 ± 32.00 
 
 
a Significant differences (P-value ≤ 0.05) as compared to their control at the same temperature. 
b Significant differences (P-value ≤ 0.05) due to temperature. 
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Figure 1 
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Figure 2 
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Table S1: Residual amino acids present in synthetic must at a specific density of 1.020 in the fermentations at 28ºC and 12ºC, expressed as the 
mean ± SEM (standard error of the mean) of the amino acid concentration (mg N /L). 
 
  Aspartic Glutamic Asparagine Serine Glutamine Histidine Glycine Threonine Arginine Alanine 
28 ºC 
         
  
hoQA23 0.57 ± 0.09 1.37 ± 0.48 0.1 ±  0.18 0.84 ± 1.00 4.27 ± 3.81 3 ± 0.51 3.53 ± 0.18 1.56 ± 0.44 24.92 ± 2.39 10.57 ± 2.04 
∆tat2 0.68 ± 0.07 1.82 ± 0.28 - 0.27 ± 0.01 6.11 ± 0.46 3 ± 0.15b 3.29 ± 0.16 1.8 ± 0.11 25.43 ± 0.33 12.78 ± 0.67 
∆trp1 0.31 ± 0.15 0.95 ± 0.35 - 0.21 ± 0.04 1.94 ± 1.10 2.04 ± 0.50b 2.8 ± 0.17a 0.7 ± 1.32 23.28 ±  2.07 6.12 ± 2.00 
hoQA23 pGREG - 1.63 ± 0.11 - 2.7 ± 0.20 28.74 ± 3.26 - 3.33 ± 0.53 1.83 ± 0.17 24.21 ± 3.13 11.18 ± 0.75 
pGREG TAT2 - 2.08 ± 0.33 - 3 ± 0.52 28.57 ± 3.51 - 3.59 ± 0.46 2.03 ± 0.38 26.13 ± 4.35 11.55 ± 1.46 
pGREG (∆trp1) - 1.62 ± 0.06 - 2.23 ± 0.50 25.44 ±  0.53 - 3.85 ± 0.98 1.5 ± 0.31 21.98 ± 1.20 9.26 ± 1.19 
pGREG TAT2 (∆trp1) - 1.07 ± 0.12a - 1.46 ± 0.27 22.51 ± 2.14 - 3.29 ± 0.07 1.04 ± 0.17 21.52 ± 0.38 7.11 ± 0.61 
12 ºC 
         
  
hoQA23 1.31 ± 0.18b 2.85 ± 0.24b 0.87 ± 0.01b 2.23 ± 0.48 27.31 ± 4.07b - 3.14 ± 0.01 1.54 ± 0.38 24.39 ± 0.89 14.43 ± 0.92 
∆tat2 0.56 ± 0.34 1.33 ± 0.78 0.77 ± 0.29 0.75 ± 0.63 15.79 ± 7.71 - 3.33 ± 0.01a 0.53 ± 0.41 22.68 ± 0.43b 8.68 ± 4.61 
∆trp1 1.49 ± 0.11b 2.88 ± 0.10b 1 ± 0.08b 2.71 ± 0.40b 32.98 ± 3.41b - 3.4 ± 0.18b 1.77 ± 0.25b 26.79 ± 1.47 15.37 ± 1.05b 
hoQA23 pGREG 1.28 ± 0.04b 2.9 ± 0.02b 0.82 ± 0.20b 1.98 ± 0.05b 31.5 ± 1.56 - 3.3 ± 0.26 1.49 ± 0.16 25.89 ±  1.62 15.15 ± 0.71b 
pGREG TAT2 1.06 ± 0.15b 2.37 ± 0.20a 0.83 ± 0.08 1.57 ± 0.31b 27.6 ± 3.18 - 2.65 ± 1.17 1.22 ± 0.23b 23.75 ± 2.15 14.26 ± 0.59b 
pGREG (∆trp1) 1.3 ± 0.38b 2.4 ± 0.58 0.63 ± 0.56 2.39 ± 0.96 30.6 ± 6.35 - 3.84 ± 0.30 1.58 ± 0.63 29 ± 1.73b 14.93 ± 2.22b 
pGREG TAT2 (∆trp1) 0.88 ± 0.78 2.25 ± 0.47b 0.89 ± 0.13b 1.76 ± 0.95 28.18 ± 6.04 - 3.97 ± 0.42 1.17 ± 0.55 26.90 ± 3.20 12.73 ± 3.25 
 
a Significant differences (P-value ≤ 0.05) as compared to their control at the same temperature. 
b Significant differences (P-value ≤ 0.05) due to temperature. 
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  Tyrosine Valine Methionine Cysteine Isoleucine Tryptophan Leucine Phenylalanine Ornithine Lysine 
28ºC 
         
  
hoQA23 0.03 ± 0.01 - 0.67 ± 0.09 1.06 ±  0.1 1.19 ± 0.10b - 0.97 ± 0.15 - 0.18 ± 0.07 0.15 ± 0.02 
∆tat2 0.04 ± 0 - 0.75 ± 0.09 1.17 ± 0.02 - 0.25 ± 0.02a 1.24 ± 0.11 - 0.23 ± 0.12 0.14 ± 0.01 
∆trp1 0.03 ± 0.1 - 0.68 ± 0.11 1.07 ± 0.05 - 0.29 ± 0.01a 1.18 ± 0.13 - 0.26 ± 0.06 0.16 ± 0.05 
hoQA23 pGREG - - 0.65 ± 0.04 0.86 ± 0.14b - 0.27 ± 0.05b 1.27 ± 0.05b - 0.28 ± 0.05b - 
pGREG TAT2 - - 1.08 ± 0.55 1.14 ± 0.20b - 0.28 ± 0.02 1.46 ± 0.25 - 0.23 ± 0.02 - 
pGREG (∆trp1) - - 0.63 ± 0.04 0.81 ± 0.09b - 0.27 ± 0.05 1.14 ± 0.16b - 0.22 ± 0.01 - 
pGREG TAT2 (∆trp1) - - 0.58 ± 0.02 0.9 ± 0.04 - 0.32 ± 0 0.86 ± 0.04b - 0.19 ± 0.08 - 
12ºC 
         
  
hoQA23 0.04 ± 0 - 0.66 ± 0.03 1.07 ± 0 - 0.1 ± 0b 1.73 ± 0.06b - 0.17 ± 0.06 0.11 ± 0.01 
∆tat2 0.03 ± 0.01 - 0.52 ± 0.08 0.98 ± 0.16 - 0.15 ± 0ab 1.14 ± 0.41 - 0.12 ± 0.01 0.05 ± 0.07 
∆trp1 0.05 ± 0 - 0.75 ± 0.08 1 ± 0.06 0.27 ± 0.38 0.49 ± 0.54 0.81 ± 1.14 - 0.2 ± 0.01 0.1 ± 0.11 
hoQA23 pGREG 0.05 ± 0.01b 0.83 ± 0.03b 0.5 ± 0.02b - - - - 0.14 ± 0.20 - 2.28 ± 0.19b 
pGREG TAT2 - 0.82 ± 0.19b 0.71 ± 0.11 - 2.4 ± 1.29b 0.19 ± 0.17 1.11 ± 1.93 11.17 ± 17.20 7.51 ± 11.36 - 
pGREG (∆trp1) 0.03 ± 0.03 0.79 ± 0.23b 0.38 ± 0.33 - 3.36 ± 0.45b 0.16 ± 0.27 - 1.08 ± 1.43 1.44 ± 0.03b 2.46 ± 0.19b 
pGREG TAT2 (∆trp1) 0.02 ± 0.02 0.31 ± 0.53 0.69 ± 0.13 0.61 ± 0.53 1.28 ± 1.28 0.16 ± 0.28 - 0.12 ± 0.21 0.12 ± 0.13a 1.23 ± 1.00 
 
a Significant differences (P-value ≤ 0.05) as compared to their control at the same temperature. 
b Significant differences (P-value ≤ 0.05) due to temperature. 
(-) not detected 
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